헬스케어 분석 시장 : 컴포넌트별, 도입 모델별, 유형별, 용도별, 최종사용자별, 지역별 - 예측(-2030년)

The healthcare analytics market is expected to grow from USD 55.52 billion in 2025 to USD 166.65 billion by 2030, with a CAGR of 24.6% during the forecast period. The adoption of Electronic Health Records (EHR) is propelling the healthcare analytics market forward. In North America, office-based physicians and non-federal acute care hospitals have adopted EHR systems.

There are government incentives available to support EHR systems through the Health Information Technology for Economic and Clinical Health Act. The forces that drive this market include advancements in artificial intelligence, value-based healthcare systems, real-world data, as well as interest in healthcare analytical services by healthcare payers, providers, life sciences companies, and post-acute organizations.

"By application, clinical analytics segment is expected to witness the highest growth during the forecast period."

Based on application, the healthcare analytics market is segmented into financial analytics, clinical analytics, operations & administrative analytics, and population health analytics. The clinical analytics segment is growing at the fastest rate during the forecast period driven by increasing adoption of AI-enabled clinical decision support, predictive risk modeling, and real-time patient insights to improve care outcomes, reduce readmissions, and support value-based care initiatives across providers and health system.

By component, services segment to witness the highest growth during the forecast period."

Based on component, the healthcare analytics market is segmented into software and services. The clinical analytics segment is growing at the fastest rate during the forecast period driven by rising demand for implementation, system integration, data management, and advanced analytics consulting as healthcare organizations seek to deploy complex AI- and cloud-based analytics platforms while ensuring interoperability, regulatory compliance, and faster time to value.

"APAC is estimated to register the highest CAGR during the forecast period."

The healthcare analytics market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The healthcare analytics market in Asia Pacific is projected to register the highest CAGR rate during the forecast period. This is driven by rapid EHR penetration, cloud-native deployments, and AI/ML adoption across providers and payers. Increasing use of population health analytics, real-world evidence, and predictive modeling, supported by government-led digital health programs and improving data interoperability standards, is accelerating large-scale analytics implementation across China, India, Japan, and Southeast Asia.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace.

• By Company Type: Tier 1 - 45%, Tier 2 - 35%, and Tier 20%
• By Designation: C-level Executives - 50%, Directors - 30%, and Others - 20%
• By Region: North America- 40%, Europe - 35%, Asia Pacific- 20% and RoW- 5%

Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US) are some of the key players in the healthcare analytics market.

The study includes an in-depth competitive analysis of these key players in the healthcare analytics market, with their company profiles, recent developments, and key market strategies.

Research Coverage

The report analyses the healthcare analytics market. It aims to estimate the market size and future growth potential of various market segments based on component, type, application, end-user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the healthcare analytics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (favorable government initiatives for electronic health record adoption, growing venture capital investments in startups, need to reduce healthcare costs, increasing focus on real-world evidence, rise of telemedicine and remote patient monitoring, growing focus on regulatory compliance), restraints (hiigh cost of analytics solutions, growing concerns about data breach), opportunities (increasing focus on value-based medicines, growing use of analytics in healthcare, rising number of patient registeries, emergence of social media and digital health technologies), and challenges (concerns regarding inaccurate and inconsistent data, reluctance to adopt healthcare analytics solutions in developing countries, lack of maintenance of medical records, shortage of skilled personnel) influencing the growth of the healthcare analytics market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare analytics market
• Market Development: Comprehensive information about lucrative markets, the report analyses the healthcare analytics market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the healthcare analytics market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US), Inovalon (US), Mckesson Corporation (US), MedeAnalytics, Inc.(US), Cotiviti, Inc. (US), Exlservice Holdings, Inc. (US), Wipro (India), among others in the healthcare analytics market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

• 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
• 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING HEALTHCARE ANALYTICS MARKET
• 2.4 HIGH-GROWTH SEGMENTS
• 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN HEALTHCARE ANALYTICS MARKET
• 3.2 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER AND COUNTRY
• 3.3 HEALTHCARE ANALYTICS MARKET, BY COUNTRY

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Favorable government initiatives for electronic health record adoption
    • 4.2.1.2 Growing venture capital investments in startups
    • 4.2.1.3 Need to reduce healthcare costs
    • 4.2.1.4 Increasing focus on real-world evidence
    • 4.2.1.5 Rise of telemedicine and remote patient monitoring
    • 4.2.1.6 Growing focus on regulatory compliance
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 High cost of analytics solutions
    • 4.2.2.2 Growing concerns about data breaches
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Increasing focus on value-based medicines
    • 4.2.3.2 Growing use of analytics in healthcare
    • 4.2.3.3 Rising number of patient registries
    • 4.2.3.4 Emergence of social media and digital health technologies
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Concerns regarding inaccurate and inconsistent data
    • 4.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries
    • 4.2.4.3 Lack of maintenance of medical records
    • 4.2.4.4 Shortage of skilled personnel
• 4.3 UNMET NEEDS AND WHITE SPACES
• 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
• 5.2 MACROECONOMIC INDICATORS
  • 5.2.1 GDP TRENDS AND FORECAST
  • 5.2.2 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
• 5.3 VALUE CHAIN ANALYSIS
• 5.4 ECOSYSTEM ANALYSIS
• 5.5 PRICING ANALYSIS
  • 5.5.1 INDICATIVE PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT
  • 5.5.2 INDICATIVE PRICING, BY REGION
• 5.6 KEY CONFERENCES AND EVENTS, 2026-2027
• 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 CASE STUDY ANALYSIS
• 5.10 IMPACT OF 2025 US TARIFF - HEALTHCARE ANALYTICS MARKET
  • 5.10.1 KEY TARIFF RATES
  • 5.10.2 PRICE IMPACT ANALYSIS
  • 5.10.3 IMPACT ON COUNTRIES/REGIONS
    • 5.10.3.1 US
    • 5.10.3.2 Europe
    • 5.10.3.3 Asia Pacific
  • 5.10.4 IMPACT ON END-USE INDUSTRY
    • 5.10.4.1 Healthcare providers
      • 5.10.4.1.1 Hospitals & health systems
      • 5.10.4.1.2 Physician groups & clinics
      • 5.10.4.1.3 Ambulatory surgery centers (ASCs)
    • 5.10.4.2 Healthcare payers
      • 5.10.4.2.1 Private insurance companies
      • 5.10.4.2.2 Government payers
    • 5.10.4.3 Pharmacies

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 TECHNOLOGY ANALYSIS
  • 6.1.1 KEY TECHNOLOGIES
    • 6.1.1.1 Big data analytics
    • 6.1.1.2 Artificial intelligence and machine learning
    • 6.1.1.3 Business intelligence tools
  • 6.1.2 COMPLEMENTARY TECHNOLOGIES
    • 6.1.2.1 Cloud computing and data integration platforms
    • 6.1.2.2 Interoperability frameworks and APIs
  • 6.1.3 ADJACENT TECHNOLOGIES
    • 6.1.3.1 Cloud computing
    • 6.1.3.2 Internet of Things
• 6.2 TECHNOLOGY/PRODUCT ROADMAP
• 6.3 PATENT ANALYSIS
  • 6.3.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ANALYTICS MARKET
  • 6.3.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 6.4 FUTURE APPLICATIONS
  • 6.4.1 AI-DRIVEN PREDICTIVE ANALYTICS AND CLINICAL DECISION SUPPORT
  • 6.4.2 REAL-WORLD EVIDENCE (RWE) AND CLINICAL RESEARCH TRANSFORMATION
  • 6.4.3 OPERATIONAL INTELLIGENCE AND HEALTHCARE SYSTEM OPTIMIZATION
• 6.5 IMPACT OF AI/GEN AI ON HEALTHCARE ANALYTICS MARKET
  • 6.5.1 MARKET POTENTIAL OF AI/GEN AI
  • 6.5.2 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION IN HEALTHCARE ANALYTICS MARKET
    • 6.5.2.1 AI-driven continuous glucose monitoring and diabetes management
  • 6.5.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
    • 6.5.3.1 Clinical development & decentralized trials
    • 6.5.3.2 Digital biomarkers & endpoint innovation
  • 6.5.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN HEALTHCARE ANALYTICS MARKET
    • 6.5.4.1 User readiness
      • 6.5.4.1.1 User A: Hospitals, clinics & long-term care providers
      • 6.5.4.1.2 User B: Pharma and biotech companies
    • 6.5.4.2 Impact assessment
      • 6.5.4.2.1 User A: Hospitals, clinics & long-term care providers
        • 6.5.4.2.1.1 Implementation
        • 6.5.4.2.1.2 Impact
      • 6.5.4.2.2 User B: Healthcare payers
        • 6.5.4.2.2.1 Implementation
        • 6.5.4.2.2.2 Impact

7 REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 7.1.1 GOVERNMENT REGULATIONS
    • 7.1.1.1 US
    • 7.1.1.2 Europe
    • 7.1.1.3 China
    • 7.1.1.4 Japan
    • 7.1.1.5 India
  • 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.3 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

• 8.1 DECISION-MAKING PROCESS
• 8.2 KEY STAKEHOLDERS IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
  • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.2.2 BUYING CRITERIA
• 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
• 8.4 UNMET NEEDS FROM END-USE INDUSTRIES
  • 8.4.1 UNMET NEEDS
  • 8.4.2 END-USER EXPECTATIONS
• 8.5 MARKET PROFITABILITY

9 HEALTHCARE ANALYTICS MARKET, BY COMPONENT

• 9.1 INTRODUCTION
• 9.2 SERVICES
  • 9.2.1 MANAGED SERVICES
    • 9.2.1.1 Analytics operations
      • 9.2.1.1.1 Continuous performance monitoring reshapes managed analytics delivery models
    • 9.2.1.2 Infrastructure & cloud management
      • 9.2.1.2.1 Cloud-native infrastructure services underpin healthcare analytics scalability
  • 9.2.2 PROFESSIONAL SERVICES
    • 9.2.2.1 Training & education
      • 9.2.2.1.1 Workforce upskilling becomes critical enabler of analytics transformation
    • 9.2.2.2 Implementation & integration
      • 9.2.2.2.1 Interoperability mandates catalyze complex analytics integration engagements
    • 9.2.2.3 Consulting
      • 9.2.2.3.1 Strategic data governance consulting unlocks organizational analytics readiness
    • 9.2.2.4 Support & maintenance
      • 9.2.2.4.1 Post-deployment support sustains long-term analytics performance and compliance
• 9.3 SOFTWARE
  • 9.3.1 POINT ANALYTICS SOLUTIONS
    • 9.3.1.1 Targeted problem-solving drives rapid adoption of specialized analytics tools
  • 9.3.2 ENTERPRISE-WIDE ANALYTICS PLATFORMS
    • 9.3.2.1 Unified data platforms enable cross-continuum analytics at enterprise scale

10 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL

• 10.1 INTRODUCTION
• 10.2 ON-PREMISES
• 10.3 CLOUD-BASED

11 HEALTHCARE ANALYTICS MARKET, BY TYPE

• 11.1 INTRODUCTION
• 11.2 DESCRIPTIVE ANALYTICS
  • 11.2.1 INCREASING USE IN PATIENT POPULATION MANAGEMENT AND FINANCIAL MANAGEMENT TO BOOST MARKET
• 11.3 PREDICTIVE ANALYTICS
  • 11.3.1 AI-POWERED RISK MODELS TRANSFORM PROACTIVE CLINICAL AND OPERATIONAL PLANNING
• 11.4 PRESCRIPTIVE ANALYTICS
  • 11.4.1 NEXT-BEST-ACTION OPTIMIZATION ELEVATES ANALYTICS FROM INSIGHT TO AUTOMATED INTERVENTION
• 11.5 DIAGNOSTIC ANALYTICS
  • 11.5.1 ROOT-CAUSE INTELLIGENCE DRIVES SYSTEMATIC QUALITY AND COST PERFORMANCE IMPROVEMENT

12 HEALTHCARE ANALYTICS MARKET, BY APPLICATION

• 12.1 INTRODUCTION
• 12.2 FINANCIAL ANALYTICS
  • 12.2.1 CLAIMS ANALYTICS
    • 12.2.1.1 Automated claims intelligence reduces revenue leakage and administrative burden
  • 12.2.2 REVENUE CYCLE MANAGEMENT
    • 12.2.2.1 End-to-end revenue intelligence optimizes margins across care continuum
  • 12.2.3 FRAUD, WASTE, & ABUSE ANALYTICS
    • 12.2.3.1 AI-powered detection frameworks reduce healthcare fraud and improper payments
  • 12.2.4 RISK ADJUSTMENT & PAYMENT INTEGRITY
    • 12.2.4.1 Accurate risk coding drives financial sustainability in value-based health plans
• 12.3 CLINICAL ANALYTICS
  • 12.3.1 CLINICAL DECISION SUPPORT
    • 12.3.1.1 Real-time evidence delivery at point of care transforms clinical outcomes
  • 12.3.2 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
    • 12.3.2.1 National quality benchmarks propel data-driven performance accountability
  • 12.3.3 MEDICAL IMAGING ANALYTICS
    • 12.3.3.1 AI-augmented imaging analysis accelerates diagnostic throughput and accuracy
  • 12.3.4 REMOTE PATIENT MONITORING ANALYTICS
    • 12.3.4.1 Wearable data integration expands longitudinal analytics beyond clinical walls
  • 12.3.5 PRECISION HEALTH ANALYTICS
    • 12.3.5.1 Genomic and multi-omics data convergence enables personalized care delivery
• 12.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS
  • 12.4.1 SUPPLY CHAIN ANALYTICS
    • 12.4.1.1 Predictive supply intelligence mitigates healthcare cost and shortage risks
  • 12.4.2 WORKFORCE ANALYTICS
    • 12.4.2.1 Predictive staffing models address healthcare talent shortages and labor costs
  • 12.4.3 STRATEGIC ANALYTICS
    • 12.4.3.1 Real-time visibility optimizes patient flow across complex care environments
  • 12.4.4 CAPACITY & WORKFLOW ANALYTICS
    • 12.4.4.1 Rising adoption of capacity & workflow analytics
• 12.5 POPULATION HEALTH ANALYTICS
  • 12.5.1 CHRONIC DISEASE MANAGEMENT
    • 12.5.1.1 Implementing predictive analytics for early identification and proactive management of high-risk chronic disease patients
  • 12.5.2 PREVENTIVE CARE ANALYTICS
    • 12.5.2.1 Screening gap identification drives proactive population wellness interventions
  • 12.5.3 VALUE-BASED CARE ANALYTICS
    • 12.5.3.1 Total cost of care intelligence enables sustainable value-based contract performance
  • 12.5.4 RISK STRATIFICATION
    • 12.5.4.1 Predictive scoring models enable precision targeting of high-risk individuals
• 12.6 PATIENT JOURNEY & ENGAGEMENT ANALYTICS
  • 12.6.1 PATIENT COMMUNICATION & OUTREACH ANALYTICS
    • 12.6.1.1 Multichannel analytics optimizes outreach precision and patient response rates
  • 12.6.2 PATIENT ADHERENCE ANALYTICS
    • 12.6.2.1 Behavioral data insights drive targeted interventions to improve treatment compliance
  • 12.6.3 PATIENT EXPERIENCE ANALYTICS
    • 12.6.3.1 Satisfaction intelligence transforms patient-centered care accountability

13 HEALTHCARE ANALYTICS MARKET, BY END USER

• 13.1 INTRODUCTION
• 13.2 HEALTHCARE PROVIDERS
  • 13.2.1 HOSPITALS & HEALTH SYSTEMS
    • 13.2.1.1 Enterprise analytics integration drives system-wide performance accountability
  • 13.2.2 PHYSICIAN GROUPS & CLINICS
    • 13.2.2.1 Value-based contracts drive analytics adoption in ambulatory care settings
  • 13.2.3 AMBULATORY SURGERY CENTERS
    • 13.2.3.1 Operational transparency and quality metrics drive ASC Analytics investment
  • 13.2.4 OTHER PROVIDERS
• 13.3 HEALTHCARE PAYERS
  • 13.3.1 PRIVATE INSURANCE COMPANIES
    • 13.3.1.1 Actuarial intelligence and member analytics sustain commercial plan competitiveness
  • 13.3.2 GOVERNMENT PAYERS
    • 13.3.2.1 Federal efficiency mandates accelerate analytics in public payer programs
  • 13.3.3 OTHER PAYERS
• 13.4 PHARMACIES
• 13.5 OTHER END USERS

14 HEALTHCARE ANALYTICS MARKET, BY REGION

• 14.1 INTRODUCTION
• 14.2 NORTH AMERICA
  • 14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 14.2.2 US
    • 14.2.2.1 High adoption of electronic health records to drive market
  • 14.2.3 CANADA
    • 14.2.3.1 Need for managing patient volumes, clinical data, and healthcare costs to favor market
• 14.3 EUROPE
  • 14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 14.3.2 GERMANY
    • 14.3.2.1 Government initiatives to increase use of analytics in healthcare to drive market
  • 14.3.3 UK
    • 14.3.3.1 Availability of venture capital investments to drive market
  • 14.3.4 FRANCE
    • 14.3.4.1 Strong financial support for digital health to augment market
  • 14.3.5 ITALY
    • 14.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions
  • 14.3.6 SPAIN
    • 14.3.6.1 Growing adoption of personalized medicine to drive market
  • 14.3.7 REST OF EUROPE
• 14.4 ASIA PACIFIC
  • 14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 14.4.2 JAPAN
    • 14.4.2.1 Rising geriatric population to drive demand for effective patient management solutions
  • 14.4.3 CHINA
    • 14.4.3.1 Favorable reforms and growing number of electronic health records to aid market growth
  • 14.4.4 INDIA
    • 14.4.4.1 Favorable government initiatives to fuel market
  • 14.4.5 AUSTRALIA
    • 14.4.5.1 Strong digital health ecosystem and government-led initiatives to drive healthcare analytics adoption
  • 14.4.6 SOUTH KOREA
    • 14.4.6.1 Favorable government initiatives and strong digital health ecosystem to fuel market growth
  • 14.4.7 REST OF ASIA PACIFIC
• 14.5 LATIN AMERICA
  • 14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 14.5.2 BRAZIL
    • 14.5.2.1 Growing adoption of digital solutions in healthcare to boost market
  • 14.5.3 MEXICO
    • 14.5.3.1 Growing prominence of startups and rising R&D activity to propel market
  • 14.5.4 REST OF LATIN AMERICA
• 14.6 MIDDLE EAST & AFRICA
  • 14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 14.6.2 GCC COUNTRIES
    • 14.6.2.1 Rising investments and developing healthcare infrastructure to drive market
  • 14.6.3 SAUDI ARABIA
    • 14.6.3.1 Strong government-led digital health transformation to fuel market
  • 14.6.4 UAE
    • 14.6.4.1 Strong government-led digital health transformation to drive market
  • 14.6.5 REST OF GCC COUNTRIES
    • 14.6.5.1 Strong government-led digital health transformation to fuel market
  • 14.6.6 SOUTH AFRICA
    • 14.6.6.1 Favorable government-led digital health transformation and rising disease burden to fuel market
  • 14.6.7 REST OF MIDDLE EAST & AFRICA

15 COMPETITIVE LANDSCAPE

• 15.1 INTRODUCTION
• 15.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023-2026
• 15.3 REVENUE ANALYSIS, 2021-2025
• 15.4 MARKET SHARE ANALYSIS, 2025
• 15.5 BRAND/SOFTWARE COMPARISON
• 15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 15.6.1 STARS
  • 15.6.2 EMERGING LEADERS
  • 15.6.3 PERVASIVE PLAYERS
  • 15.6.4 PARTICIPANTS
  • 15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 15.6.5.1 Company footprint
    • 15.6.5.2 Region footprint
    • 15.6.5.3 Component footprint
    • 15.6.5.4 Application footprint
    • 15.6.5.5 End user footprint
• 15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 15.7.1 PROGRESSIVE COMPANIES
  • 15.7.2 RESPONSIVE COMPANIES
  • 15.7.3 DYNAMIC COMPANIES
  • 15.7.4 STARTING BLOCKS
  • 15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
    • 15.7.5.1 Detailed list of key startups/SMEs
    • 15.7.5.2 Competitive benchmarking of key startups/SMEs
• 15.8 COMPANY VALUATION AND FINANCIAL METRICS
• 15.9 COMPETITIVE SCENARIO
  • 15.9.1 PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
  • 15.9.2 DEALS
  • 15.9.3 EXPANSIONS

16 COMPANY PROFILES

• 16.1 KEY PLAYERS
  • 16.1.1 MERATIVE
    • 16.1.1.1 Business overview
    • 16.1.1.2 Products/Solutions/Services offered
    • 16.1.1.3 Recent developments
      • 16.1.1.3.1 Product launches/enhancements/approvals
      • 16.1.1.3.2 Deals
    • 16.1.1.4 MnM view
      • 16.1.1.4.1 Right to Win
      • 16.1.1.4.2 Strategic choices
      • 16.1.1.4.3 Weaknesses and competitive threats
  • 16.1.2 SAS INSTITUTE INC.
    • 16.1.2.1 Business overview
    • 16.1.2.2 Products/Solutions/Services offered
    • 16.1.2.3 Recent developments
      • 16.1.2.3.1 Product launches/enhancements/approvals
    • 16.1.2.4 MnM view
      • 16.1.2.4.1 Right to Win
      • 16.1.2.4.2 Strategic choices
      • 16.1.2.4.3 Weaknesses and competitive threats
  • 16.1.3 OPTUM, INC.
    • 16.1.3.1 Business overview
    • 16.1.3.2 Products/Solutions/Services offered
    • 16.1.3.3 Recent developments
      • 16.1.3.3.1 Product launches and approvals
      • 16.1.3.3.2 Deals
    • 16.1.3.4 MnM view
      • 16.1.3.4.1 Right to Win
      • 16.1.3.4.2 Strategic choices
      • 16.1.3.4.3 Weaknesses and competitive threats
  • 16.1.4 ORACLE
    • 16.1.4.1 Business overview
    • 16.1.4.2 Products/Solutions/Services offered
    • 16.1.4.3 Recent developments
      • 16.1.4.3.1 Product launches/enhancements/approvals
      • 16.1.4.3.2 Deals
    • 16.1.4.4 MnM view
      • 16.1.4.4.1 Right to Win
      • 16.1.4.4.2 Strategic choices
      • 16.1.4.4.3 Weaknesses and competitive threats
  • 16.1.5 HEALTH CATALYST
    • 16.1.5.1 Business overview
    • 16.1.5.2 Products/Solutions/Services offered
    • 16.1.5.3 Recent developments
      • 16.1.5.3.1 Product launches/enhancements/approvals
      • 16.1.5.3.2 Deals
    • 16.1.5.4 MnM view
      • 16.1.5.4.1 Right to Win
      • 16.1.5.4.2 Strategic choices
      • 16.1.5.4.3 Weaknesses and competitive threats
  • 16.1.6 EXLSERVICE HOLDINGS, INC.
    • 16.1.6.1 Business overview
    • 16.1.6.2 Products/Solutions/Services offered
    • 16.1.6.3 Recent developments
      • 16.1.6.3.1 Deals
      • 16.1.6.3.2 Other developments
    • 16.1.6.4 MnM view
      • 16.1.6.4.1 Right to Win
      • 16.1.6.4.2 Strategic choices
      • 16.1.6.4.3 Weaknesses and competitive threats
  • 16.1.7 VERADIGM LLC
    • 16.1.7.1 Business overview
    • 16.1.7.2 Products/Solutions/Services offered
    • 16.1.7.3 Recent developments
      • 16.1.7.3.1 Product launches/enhancements/approvals
      • 16.1.7.3.2 Deals
      • 16.1.7.3.3 Other developments
    • 16.1.7.4 MnM view
      • 16.1.7.4.1 Right to Win
      • 16.1.7.4.2 Strategic choices
      • 16.1.7.4.3 Weaknesses and competitive threats
  • 16.1.8 CITIUSTECH INC.
    • 16.1.8.1 Business overview
    • 16.1.8.2 Products/Solutions/Services offered
    • 16.1.8.3 Recent developments
      • 16.1.8.3.1 Product launches/enhancements/approvals
      • 16.1.8.3.2 Deals
      • 16.1.8.3.3 Expansions
  • 16.1.9 CVS HEALTH
    • 16.1.9.1 Business overview
    • 16.1.9.2 Products/Solutions/Services offered
    • 16.1.9.3 Recent developments
      • 16.1.9.3.1 Product launches/enhancements/approvals
      • 16.1.9.3.2 Deals
  • 16.1.10 INOVALON
    • 16.1.10.1 Business overview
    • 16.1.10.2 Products/Solutions/Services offered
    • 16.1.10.3 Recent developments
      • 16.1.10.3.1 Product launches/enhancements/approvals
      • 16.1.10.3.2 Deals
      • 16.1.10.3.3 Expansions
      • 16.1.10.3.4 Other developments
  • 16.1.11 MCKESSON CORPORATION
    • 16.1.11.1 Business overview
    • 16.1.11.2 Products/Solutions/Services offered
    • 16.1.11.3 Recent developments
      • 16.1.11.3.1 Deals
  • 16.1.12 MEDEANALYTICS, INC.
    • 16.1.12.1 Business overview
    • 16.1.12.2 Products/Solutions/Services offered
    • 16.1.12.3 Recent developments
      • 16.1.12.3.1 Deals
  • 16.1.13 COTIVITI, INC.
    • 16.1.13.1 Business overview
    • 16.1.13.2 Products/Solutions/Services offered
  • 16.1.14 DATAVANT, INC.
    • 16.1.14.1 Business overview
    • 16.1.14.2 Products/Solutions/Services offered
    • 16.1.14.3 Recent developments
      • 16.1.14.3.1 Product launches/enhancements/approvals
      • 16.1.14.3.2 Deals
  • 16.1.15 DEFINITIVE HEALTHCARE, LLC
    • 16.1.15.1 Business overview
    • 16.1.15.2 Products/Solutions/Services offered
    • 16.1.15.3 Recent developments
      • 16.1.15.3.1 Product launches/enhancements/approvals
      • 16.1.15.3.2 Deals
  • 16.1.16 KOMODO HEALTH, INC.
    • 16.1.16.1 Business overview
    • 16.1.16.2 Products/Solutions/Services offered
    • 16.1.16.3 Recent developments
      • 16.1.16.3.1 Product launches/enhancements/approvals
      • 16.1.16.3.2 Deals
  • 16.1.17 ATHENAHEALTH, INC.
    • 16.1.17.1 Business overview
    • 16.1.17.2 Products/Solutions/Services offered
    • 16.1.17.3 Recent developments
      • 16.1.17.3.1 Product launches/enhancements/approvals
      • 16.1.17.3.2 Deals
  • 16.1.18 IQVIA
    • 16.1.18.1 Business overview
    • 16.1.18.2 Products/Solutions/Services offered
    • 16.1.18.3 Recent developments
      • 16.1.18.3.1 Product launches/enhancements/approvals
      • 16.1.18.3.2 Deals
  • 16.1.19 WIPRO
    • 16.1.19.1 Business overview
    • 16.1.19.2 Products/Solutions/Services offered
  • 16.1.20 CLOUDERA, INC.
    • 16.1.20.1 Business overview
    • 16.1.20.2 Products/Solutions/Services offered
    • 16.1.20.3 Recent developments
      • 16.1.20.3.1 Product launches/enhancements/approvals
      • 16.1.20.3.2 Deals
• 16.2 OTHER PLAYERS
  • 16.2.1 HEALTHVERITY, INC.
  • 16.2.2 KYRUUS, INC.
  • 16.2.3 HEALTHCORUM
  • 16.2.4 LUMA HEALTH INC.
  • 16.2.5 VALIDIC, INC.

17 RESEARCH METHODOLOGY

• 17.1 RESEARCH APPROACH
  • 17.1.1 SECONDARY RESEARCH
    • 17.1.1.1 Key data from secondary sources
  • 17.1.2 PRIMARY RESEARCH
    • 17.1.2.1 Primary sources
    • 17.1.2.2 Key data from primary sources
    • 17.1.2.3 Breakdown of primary interviews
    • 17.1.2.4 Insights from primary experts
• 17.2 RESEARCH METHODOLOGY DESIGN
• 17.3 MARKET SIZE ESTIMATION
• 17.4 DATA TRIANGULATION
• 17.5 RESEARCH ASSUMPTIONS
• 17.6 RESEARCH LIMITATIONS
  • 17.6.1 METHODOLOGY-RELATED
  • 17.6.2 SCOPE-RELATED
• 17.7 RISK ASSESSMENT

18 APPENDIX

• 18.1 DISCUSSION GUIDE
• 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 18.3 CUSTOMIZATION OPTIONS
• 18.4 RELATED REPORTS
• 18.5 AUTHOR DETAILS